Technology Biologics, research services to be main drivers of growth in FY19, says Biocon Updated : April 30, 2018 12:59 PM IST The biologics and research services businesses of the company grew by 47% and 45%, respectively, in the fourth quarter of the fiscal year 2018. The company has previously guided for USD 200 million in revenue from its biologics business and USD 250 million from research services business by FY19, and are on track to achieve those. The Bengaluru-based firm had posted 2% increase in its consolidated net profit at Rs 130 crore for the fourth quarter ended March of 2017-18. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.